109205 ⎘
Structure or type of the nucleic acid; Chemical structure; Nature of the modification linked to the nucleic acid via an atom other than carbon
COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION
#2CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
#3ACYLATED tRNA, INTRODUCTION OF PHARMACOLOGICALLY ACTIVE MOTIF IN PEPTIDE USING RIBOSOME CATALYSIS AND METHOD OF PREPARING SAME
#4FACTOR XII (F12) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#5COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION
#6Compositions and methods for modulating apolipoprotein (a) expression
#7CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
#8Factor XII (F12) iRNA compositions and methods of use thereof
#9LONG CHAIN CARBON AND CYCLIC AMINO ACIDS SUBSTRATES FOR GENETIC CODE REPROGRAMMING
#10COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION
#11COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION
#12Functionally-Modified Oligonucleotides And Subunits Thereof
#13COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION
#14TMPRSS6 iRNA compositions and methods of use thereof
#15COMPOSITIONS AND METHODS
#16Compositions and methods for modulating apolipoprotein (a) expression
#17COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION
#18COMPOSITIONS AND METHODS FOR MODULATING HBV EXPRESSION
#19Functionally-modified oligonucleotides and subunits thereof
#20Modified L-Nucleic Acid
#21Conjugated antisense compounds and their use
#22TMPRSS6 iRNA compositions and methods of use thereof
#23Universal enzyme responsive linker for assembling ligands on DNA functionalized nanomaterials
#24COMPOSITIONS AND METHODS FOR MODULATING HBV EXPRESSION
#25Chimeric decoy
#26Compositions and methods for modulating apolipoprotein (a) expression
#27Compositions and methods for modulating apolipoprotein C-III expression
#28Universal enzyme responsive linker for assembling ligands on DNA functionalized nanomaterials
#29Functionally-modified oligonucleotides and subunits thereof
#30Modified L-Nucleic Acid
#31Compositions and methods for modulating TTR expression
#32COMPOSITIONS AND METHODS
#33TMPRSS6 iRNA compositions and methods of use thereof
#34SiRNA targeting PRK2, which is hepatitis C virus therapeutic agent
#35Modified L-Nucleic Acid
#36Functionally-modified oligonucleotides and subunits thereof
#37Compositions and methods for modulating apolipoprotein (a) expression
#38Compositions and methods for modulating apolipoprotein C-III expression
#39Compositions and methods
#40Compositions and methods for modulating HBV expression
#41Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
#42Methods of treating a metabolic syndrome by modulating heat shock protein (HSP) 90-beta
#43POLYNUCLEOTIDE-POLY(DIOL) CONJUGATES, PROCESS OF PREPARATION AND USES THEREOF
#44Expression of maize codon optimized proteins in pseudomonas fluorescens
#45Methods for arranging and packing nucleic acids for unusual resistance to nucleases and targeted delivery for gene therapy
#46Compositions and methods for modulating apolipoprotein (a) expression
#47Compositions and methods for modulating apolipoprotein C-III expression
#48Conjugated antisense compounds and their use
#49Conjugated antisense compounds and their use
#50Modified L-Nucleic Acid
#51Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
#52RNA Interference Mediated Inhibition of BTB and CNC Homology 1, Basic Leucine Zipper Transcription Factor 1 (BACH1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
#53Modified L-Nucleic Acid
#54Modulation of Immunostimulatory Properties of Short Interfering Ribonucleic Acid (Sirna) by Nucleotide Modification
#55Modified L-nucleic acid
#562' Modified oligonucleotides
#57Conjugated antisense compounds and their use